Literature DB >> 3947540

Necrobiotic xanthogranuloma: a report of four cases.

C A Holden, R K Winkelmann, E Wilson Jones.   

Abstract

Four patients are described who demonstrate the range of clinical and pathological features seen in necrobiotic xanthogranuloma with paraproteinaemia (NXG). Each patient had the typical periorbital yellow plaques with numerous well demarcated yellow indurated plaques on the trunk. All four patients had evidence of paraproteinaemia. The histopathology showed diagnostic features of intense necrobiosis with xanthomatization, including touton giant cells and the bizarre angulated giant cells of NXG. Previously, the patients had been diagnosed as atypical necrobiosis lipoidica, and the distinction between NXG and other necrobiotic conditions is discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3947540     DOI: 10.1111/j.1365-2133.1986.tb02804.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Radiological and clinicopathological features of orbital xanthogranuloma.

Authors:  K A Miszkiel; S A Sohaib; G E Rose; I A Cree; I F Moseley
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

2.  A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria.

Authors:  Caroline A Nelson; Connie S Zhong; David A Hashemi; Hovik J Ashchyan; Zoe Brown-Joel; Megan H Noe; Sotonye Imadojemu; Robert G Micheletti; Ruth Ann Vleugels; Karolyn A Wanat; Misha Rosenbach; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2020-03-01       Impact factor: 10.282

3.  Orbital xanthogranuloma in adults.

Authors:  G E Rose; B C Patel; A Garner; J E Wright
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

Review 4.  Systemic therapy of necrobiotic xanthogranuloma: a systematic review.

Authors:  Lisa Steinhelfer; Thomas Kühnel; Herbert Jägle; Stephanie Mayer; Sigrid Karrer; Frank Haubner; Stephan Schreml
Journal:  Orphanet J Rare Dis       Date:  2022-03-24       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.